USMLE Step 1 & 2 Lung Cancer

Last updated: May 2, 2026

Lung Cancer questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.

The rule

Lung cancer is split first into small cell lung cancer (SCLC, ~15%) and non-small cell lung cancer (NSCLC, ~85%), because SCLC is almost always disseminated at diagnosis and treated with chemotherapy/radiation rather than surgery, while early-stage NSCLC is potentially curable with resection. Within NSCLC, adenocarcinoma is peripheral and the most common subtype overall (and in never-smokers and women), squamous cell is central and cavitating with strong smoking link, and large cell is peripheral and undifferentiated. Each subtype has signature paraneoplastic syndromes you are expected to match on sight: squamous → PTHrP-mediated hypercalcemia; small cell → SIADH, ectopic ACTH (Cushing), and Lambert-Eaton; adenocarcinoma → hypertrophic osteoarthropathy. The single most important branch point on the exam is whether the tumor is SCLC (no surgery, even for limited stage in most cases) versus NSCLC (resect if stage I-II, no distant mets, adequate pulmonary reserve).

Elements breakdown

Small Cell Lung Cancer (SCLC)

Neuroendocrine malignancy of central airways, almost exclusively in smokers, that disseminates early.

  • Central location, hilar mass
  • Strong smoking association
  • Neuroendocrine markers: chromogranin, synaptophysin
  • Kulchitsky cells, small dark blue cells, salt-and-pepper chromatin
  • Treated with chemo + radiation, not surgery

Common examples:

  • SIADH (ectopic ADH)
  • Ectopic ACTH → Cushing
  • Lambert-Eaton myasthenic syndrome (anti-VGCC)

Squamous Cell Carcinoma (NSCLC)

Central NSCLC arising from bronchial epithelium with keratinization.

  • Central location, may cavitate
  • Strong smoking association
  • Keratin pearls, intercellular bridges
  • PTHrP secretion → hypercalcemia

Common examples:

  • Hypercalcemia of malignancy via PTHrP
  • Hemoptysis from central airway erosion

Adenocarcinoma (NSCLC)

Peripheral NSCLC arising from glandular/alveolar epithelium; most common subtype overall.

  • Peripheral location
  • Most common in never-smokers and women
  • Glandular architecture, mucin production
  • Driver mutations: EGFR, ALK, KRAS
  • TTF-1 positive

Common examples:

  • Hypertrophic pulmonary osteoarthropathy (clubbing + periostitis)
  • Pleural effusion / lepidic spread

Large Cell Carcinoma (NSCLC)

Peripheral, poorly differentiated NSCLC of exclusion.

  • Peripheral location
  • Undifferentiated large cells, no glandular or squamous features
  • Poor prognosis

Common examples:

  • Occasional gynecomastia (β-hCG secretion)

Carcinoid Tumor

Low-grade neuroendocrine tumor, often central, not smoking-related.

  • Central polypoid endobronchial mass
  • Chromogranin/synaptophysin positive
  • Recurrent pneumonia from bronchial obstruction
  • Carcinoid syndrome rare unless hepatic mets

Common examples:

  • Flushing, diarrhea, wheezing if metastatic

Anatomic Complication Syndromes

Patterns produced by tumor location independent of histology.

  • Pancoast (superior sulcus): shoulder pain, Horner, T1 weakness
  • SVC syndrome: facial swelling, distended neck veins
  • Recurrent laryngeal nerve palsy: hoarseness
  • Phrenic nerve palsy: elevated hemidiaphragm
  • Malignant pleural effusion → stage IV

Common examples:

  • Horner syndrome: ptosis, miosis, anhidrosis
  • SVC obstruction often from right-sided central tumor

Common patterns and traps

The Paraneoplastic-to-Histology Map

USMLE loves to give you a paraneoplastic finding (hypercalcemia, hyponatremia, Cushingoid features, proximal weakness improving with use, clubbing) and force you to back-derive the histology. The pattern is high-yield because the syndrome is often the only specific clue — the imaging may just say 'lung mass.' You are expected to know PTHrP → squamous, SIADH/ACTH/Lambert-Eaton → small cell, hypertrophic osteoarthropathy → adenocarcinoma cold.

A wrong choice will offer the histology that matches the location described in the vignette but not the paraneoplastic syndrome — e.g., 'adenocarcinoma' for a peripheral mass when the labs scream PTHrP-driven hypercalcemia (squamous).

The SCLC Surgery Trap

When the vignette describes a limited-stage central tumor in a smoker with neuroendocrine features or a paraneoplastic syndrome (SIADH, ectopic ACTH), candidates trained on 'early stage = resect' will pick lobectomy. Small cell is almost always considered systemic at diagnosis because of micrometastases, so the answer is platinum-based chemotherapy with concurrent thoracic radiation, not surgery. Only a tiny subset of T1-2N0 SCLC patients are surgical candidates, and the exam rarely tests that exception.

The wrong choice is 'lobectomy' or 'wedge resection with lymph node dissection' offered alongside the correct 'cisplatin + etoposide with concurrent radiation.'

The Pancoast/Horner Pattern

A superior sulcus (apical) tumor invades the brachial plexus (C8-T1) and the cervical sympathetic chain, producing a classic triad: shoulder/arm pain in the ulnar distribution, ipsilateral Horner syndrome (ptosis, miosis, anhidrosis), and atrophy of intrinsic hand muscles. The vignette will sometimes lead with shoulder pain treated as musculoskeletal for months — the chest imaging is the unlock.

A wrong choice is a primary musculoskeletal or neurologic dx (cervical radiculopathy, rotator cuff tear, brachial neuritis) offered before the correct 'apical lung tumor with brachial plexus and sympathetic chain involvement.'

The Solitary Pulmonary Nodule Decision Tree

An incidental nodule's malignancy risk depends on size, edge characteristics (smooth/lobulated/spiculated), growth on prior imaging, calcification pattern (popcorn = hamartoma, central/laminated = granuloma, eccentric/stippled = suspicious), and patient risk factors (age, smoking, prior cancer). Stable for ≥2 years on prior imaging or benign calcification pattern → benign, follow. High-risk features → PET, biopsy, or resection.

A wrong choice is 'repeat CT in 6 months' for a spiculated 2.5 cm nodule in a heavy smoker, when the right answer is tissue diagnosis (PET-CT then biopsy or surgical resection).

The Malignant Pleural Effusion Upstager

A malignant pleural effusion (cytology-positive, or any effusion in a patient with known lung cancer that is exudative without another cause) automatically makes the cancer stage IV (M1a) — meaning no curative resection regardless of how the primary tumor looks. Candidates fixated on tumor size and nodal status miss the effusion as the staging-defining finding.

A wrong choice is 'lobectomy with mediastinal lymph node dissection' for a small primary tumor when the vignette mentions a moderate ipsilateral pleural effusion with malignant cells on thoracentesis.

How it works

Picture a 64-year-old man with a 50-pack-year smoking history, weight loss, and a 3 cm peripheral right upper lobe nodule on CT — but his calcium is 13.2 mg/dL with a suppressed PTH and elevated PTHrP. The hypercalcemia steers you toward squamous cell carcinoma even though squamous is classically central, because PTHrP-driven hypercalcemia is the squamous paraneoplastic signature. Now flip one detail: same patient, but instead of hypercalcemia he has serum sodium of 118 mEq/L, urine osm 600, serum osm 250, and a central hilar mass. That is SIADH from small cell lung cancer, and the management pivot is enormous — no curative resection, you go straight to platinum-etoposide chemotherapy with thoracic radiation. The exam lives in this matching exercise: histology subtype ↔ location ↔ smoking link ↔ paraneoplastic syndrome ↔ treatment pathway. Get the histology right and the rest of the question usually answers itself.

Worked examples

Worked Example 1

Which of the following is the most likely histologic diagnosis?

  • A Squamous cell carcinoma
  • B Small cell lung carcinoma ✓ Correct
  • C Adenocarcinoma
  • D Pulmonary carcinoid tumor

Why B is correct: The combination of a heavy smoker, a central hilar mass with mediastinal nodes, and euvolemic hyponatremia with inappropriately concentrated urine (urine osm > serum osm, urine Na > 40) and normal cortisol/TSH is SIADH. Ectopic ADH secretion is the classic paraneoplastic syndrome of small cell lung cancer, which arises centrally from neuroendocrine (Kulchitsky) cells and is almost always associated with smoking. The seizure is from severe hyponatremia (Na 114).

Why each wrong choice fails:

  • A: Squamous cell is also central and smoking-related, but its signature paraneoplastic syndrome is PTHrP-mediated hypercalcemia, not SIADH. The labs here show hyponatremia with a normal calcium picture, which does not fit squamous. (The Paraneoplastic-to-Histology Map)
  • C: Adenocarcinoma is the most common lung cancer overall, but it is peripheral rather than central/hilar, occurs in never-smokers and women more than other subtypes, and its paraneoplastic association is hypertrophic pulmonary osteoarthropathy — not SIADH. (The Paraneoplastic-to-Histology Map)
  • D: Carcinoid tumors are also neuroendocrine and can be central, but they occur in younger non-smokers and typically present with recurrent post-obstructive pneumonia or hemoptysis. Carcinoid syndrome (flushing, diarrhea) requires hepatic metastases and does not produce SIADH as its hallmark.
Worked Example 2

Which of the following best explains this patient's neurologic findings?

  • A Compression of the recurrent laryngeal nerve by mediastinal tumor
  • B Tumor invasion of the cervical sympathetic chain and lower brachial plexus ✓ Correct
  • C Paraneoplastic autoantibodies against voltage-gated calcium channels
  • D Metastatic spread to the cervical spinal cord

Why B is correct: This is the classic Pancoast (superior sulcus) tumor presentation. Apical tumor invasion of the cervical sympathetic chain produces ipsilateral Horner syndrome (ptosis, miosis, anhidrosis), while invasion of the lower brachial plexus (C8-T1) causes ulnar-distribution arm pain, intrinsic hand muscle weakness, and atrophy. The shoulder pain treated as musculoskeletal for months before imaging is the textbook clinical lead-in.

Why each wrong choice fails:

  • A: Recurrent laryngeal nerve compression causes hoarseness from vocal cord paralysis, typically with left-sided mediastinal tumors due to the nerve's longer course around the aortic arch. It does not produce Horner syndrome or hand weakness.
  • C: Anti-VGCC antibodies cause Lambert-Eaton myasthenic syndrome, which presents with proximal muscle weakness that improves with repeated use, autonomic symptoms, and depressed reflexes — and is associated with small cell lung cancer, not an apical mass invading the brachial plexus. The focal ulnar-distribution sensory and motor findings here are anatomic, not autoimmune. (The Paraneoplastic-to-Histology Map)
  • D: Cervical cord metastasis would produce upper motor neuron signs (hyperreflexia, spasticity, Babinski) and a sensory level rather than a focal lower motor neuron pattern in a single dermatome/myotome. The findings here localize cleanly to the brachial plexus and sympathetic chain at the apex.
Worked Example 3

Which of the following best explains this patient's hypercalcemia?

  • A Ectopic secretion of parathyroid hormone-related peptide by the tumor ✓ Correct
  • B Osteolytic bone metastases releasing calcium
  • C Tumor production of 1,25-dihydroxyvitamin D
  • D Coexisting primary hyperparathyroidism

Why A is correct: The biopsy findings (keratin pearls, intercellular bridges) are diagnostic of squamous cell carcinoma, the lung cancer subtype classically associated with humoral hypercalcemia of malignancy via PTHrP. PTHrP mimics PTH at its receptor, raising serum calcium and lowering phosphate, while suppressing endogenous PTH through normal feedback — exactly the lab pattern shown. Imaging shows no bone metastases, ruling out an osteolytic mechanism.

Why each wrong choice fails:

  • B: Osteolytic metastases can cause hypercalcemia (classic in breast cancer and multiple myeloma), but the vignette specifies no distant metastases on CT. Also, the elevated PTHrP directly identifies the humoral mechanism, making local osteolysis unnecessary as an explanation.
  • C: Tumor-produced 1,25-(OH)₂ vitamin D causes hypercalcemia in granulomatous diseases (sarcoidosis, TB) and some lymphomas via macrophage 1α-hydroxylase activity, not in squamous cell lung cancer. The vignette notes a normal 25-OH vitamin D and identifies elevated PTHrP, pointing squarely at the humoral PTHrP mechanism.
  • D: Primary hyperparathyroidism would show elevated, not suppressed, intact PTH. The PTH of 8 pg/mL is appropriately suppressed by the hypercalcemia, indicating the parathyroid glands are functioning normally and the calcium elevation is driven by something else — here, PTHrP.

Memory aid

SQUAMOUS = Sentral, Smoking, cavitation, hyperCalcemia (PTHrP). SMALL CELL = Sentral, Smoking, SIADH, ACTH, lambert-Eaton. ADENO = peripherAl, never-smokers, EGFR/ALK, clubbing. LARGE = peripheraL, Lousy prognosis, gynecomastia (hCG).

Key distinction

Small cell vs. non-small cell is the make-or-break distinction: SCLC = chemo + radiation, no surgery; NSCLC stage I-II = resect. Get this wrong and you've picked the wrong management pathway entirely, regardless of how well you matched the paraneoplastic syndrome.

Summary

Match the histologic subtype to its location, smoking link, and signature paraneoplastic syndrome, then split SCLC (chemo/radiation) from NSCLC (resect early stage) to choose management.

Practice lung cancer adaptively

Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.

Start your free 7-day trial

Frequently asked questions

What is lung cancer on the USMLE Step 1 & 2?

Lung cancer is split first into small cell lung cancer (SCLC, ~15%) and non-small cell lung cancer (NSCLC, ~85%), because SCLC is almost always disseminated at diagnosis and treated with chemotherapy/radiation rather than surgery, while early-stage NSCLC is potentially curable with resection. Within NSCLC, adenocarcinoma is peripheral and the most common subtype overall (and in never-smokers and women), squamous cell is central and cavitating with strong smoking link, and large cell is peripheral and undifferentiated. Each subtype has signature paraneoplastic syndromes you are expected to match on sight: squamous → PTHrP-mediated hypercalcemia; small cell → SIADH, ectopic ACTH (Cushing), and Lambert-Eaton; adenocarcinoma → hypertrophic osteoarthropathy. The single most important branch point on the exam is whether the tumor is SCLC (no surgery, even for limited stage in most cases) versus NSCLC (resect if stage I-II, no distant mets, adequate pulmonary reserve).

How do I practice lung cancer questions?

The fastest way to improve on lung cancer is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.

What's the most important distinction to remember for lung cancer?

Small cell vs. non-small cell is the make-or-break distinction: SCLC = chemo + radiation, no surgery; NSCLC stage I-II = resect. Get this wrong and you've picked the wrong management pathway entirely, regardless of how well you matched the paraneoplastic syndrome.

Is there a memory aid for lung cancer questions?

SQUAMOUS = Sentral, Smoking, cavitation, hyperCalcemia (PTHrP). SMALL CELL = Sentral, Smoking, SIADH, ACTH, lambert-Eaton. ADENO = peripherAl, never-smokers, EGFR/ALK, clubbing. LARGE = peripheraL, Lousy prognosis, gynecomastia (hCG).

What's a common trap on lung cancer questions?

Picking surgery for limited-stage small cell

What's a common trap on lung cancer questions?

Confusing PTHrP hypercalcemia (squamous) with SIADH hyponatremia (small cell)

Related USMLE Step 1 & 2 sub-topics

Ready to drill these patterns?

Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more lung cancer questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.

Start your free 7-day trial